Why topical prasterone (DHEA) avoids systemic endometrial risks compared to oral oestrogens? episode artwork

EPISODE · Jul 15, 2026 · 19 MIN

Why topical prasterone (DHEA) avoids systemic endometrial risks compared to oral oestrogens?

from Women’s Health & Wellness · host The Womens Health Clinic

Finding Relief: A Guide to Vaginal DHEA (Prasterone) for Intimate Menopause Symptoms Menopause is a profound transition, and while we often hear about hot flushes and night sweats, some of the most challenging symptoms are the ones women are least likely to talk about. If you are experiencing vaginal dryness, irritation, or pain during sexual intimacy, you are not alone. These symptoms are incredibly common, but the good news is that they are...Read the full clinical guide: https://thewomenshealthclinic.co.uk/why-does-topical-prasterone-dhea-therapy-avoid-the-systemic-endometrial-risks-associated-with-traditional-oral-estrogen-for-dryness/This clinical audio overview covers the latest standards in patient care and research.

Episode metadata supplied by the publisher feed · Published Jul 15, 2026

Embed this episode

NOW PLAYING

Why topical prasterone (DHEA) avoids systemic endometrial risks compared to oral oestrogens?

0:00 19:15

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Women’s Health & Wellness?

This episode is 19 minutes long.

When was this Women’s Health & Wellness episode published?

This episode was published on July 15, 2026.

Can I download this Women’s Health & Wellness episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!